HIV Survivors Seek Drug Advances as FDA Eases Approvals
This article is for subscribers only.
Harold Fuller has run out of options to keep his HIV at bay.
Fuller, 56, of Brooklyn, New York, has lived with the virus for 20 years. Earlier in his illness, he stayed ahead of HIV’s ability to mutate by changing medicines every two years. For the past five years, though, Fuller has had to take the same pills because of a lack of new treatments.